Inventor
BRANN MARK R
US24 patents
⚠️ This page may combine multiple inventors who share the name “BRANN MARK R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACADIA PHARM INC
20 patentsUS7601740B2Oct 13, 2009
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC60 citations99
US8921393B2Dec 30, 2014
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC41 citations98
US9566271B2Feb 14, 2017
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC17 citations96
US9211289B2Dec 15, 2015
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC20 citations96
US8377959B2Feb 19, 2013
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC26 citations96
US8008323B2Aug 30, 2011
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC25 citations96
US7994193B2Aug 9, 2011
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC29 citations96
US7863296B2Jan 4, 2011
Selective serotonin receptor inverse agonists as therapeutics for disease
ACADIA PHARM INC47 citations96
US7732462B2Jun 8, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC36 citations96
US7659285B2Feb 9, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC33 citations96
US7713995B2May 11, 2010
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC30 citations95
US10525046B2Jan 7, 2020
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC12 citations94
US8618130B2Dec 31, 2013
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC25 citations94
US10028944B2Jul 24, 2018
Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
ACADIA PHARM INC15 citations92
US7875632B2Jan 25, 2011
Selective serotonin receptor inverse agonists as therapeutics for disease
ACADIA PHARM INC23 citations92
US7820695B2Oct 26, 2010
Selective serotonin receptor inverse agonists as therapeutics for disease
ACADIA PHARM INC25 citations92
US7348140B1Mar 25, 2008
Clinical indications for genotyping polymorphic variants of G-protein coupled receptors
ACADIA PHARM INC8 citations68
US7491503B2Feb 17, 2009
Identification of ligands by selective amplification of cells transfected with receptors
ACADIA PHARM INC0 citations52
US7452682B2Nov 18, 2008
Identification of 5HT2A receptor ligands by selective amplification of cells transfected with receptors
ACADIA PHARM INC0 citations52
US7425420B2Sep 16, 2008
Identification of ligands by selective amplification of cells transfected with a 5HT2A receptor
ACADIA PHARM INC0 citations52